Human apoA-I increases macrophage foam cell derived PLTP activity without affecting the PLTP mass
详细信息 查看全文
- 作者：Marius R Robciuc (1)
Jari Metso (1)
Anca Sima (2)
Christian Ehnholm (1)
Matti Jauhiainen (1) - 刊名：Lipids in Health and Disease
- 出版年：2010
- 出版时间：December 2010
- 年：2010
- 卷：9
- 期：1
- 全文大小：959KB
- 参考文献：1. Rocha VZ, Libby P: Obesity, inflammation, and atherosclerosis. / Nat Rev Cardiol 2009,6(6):399鈥?09. CrossRef
2. Duffy D, Rader DJ: Update on strategies to increase HDL quantity and function. / Nat Rev Cardiol 2009,6(7):455鈥?63. CrossRef
3. Escola-Gil JC, Rotllan N, Julve J, Blanco-Vaca F: In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotection. / Atherosclerosis 2009,206(2):321鈥?27. CrossRef
4. Laffitte BA, Joseph SB, Chen M, Castrillo A, Repa J, Wilpitz D, Mangelsdorf D, Tontonoz P: The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions. / Mol Cell Biol 2003,23(6):2182鈥?191. CrossRef
5. Desrumaux CM, Mak PA, Boisvert WA, Masson D, Stupack D, Jauhiainen M, Ehnholm C, Curtiss LK: Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells. / J Lipid Res 2003,44(8):1453鈥?461. CrossRef
6. O'Brien KD, Vuletic S, McDonald TO, Wolfbauer G, Lewis K, Tu AY, Marcovina S, Wight TN, Chait A, Albers JJ: Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis. / Circulation 2003,108(3):270鈥?74. CrossRef
7. Vikstedt R, Ye D, Metso J, Hildebrand RB, Van Berkel TJ, Ehnholm C, Jauhiainen M, Van Eck M: Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development. / Arterioscler Thromb Vasc Biol 2007,27(3):578鈥?86. CrossRef
8. Valenta DT, Ogier N, Bradshaw G, Black AS, Bonnet DJ, Lagrost L, Curtiss LK, Desrumaux CM: Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression. / Arterioscler Thromb Vasc Biol 2006,26(7):1572鈥?578. CrossRef
9. Oram JF, Wolfbauer G, Vaughan AM, Tang C, Albers JJ: Phospholipid transfer protein interacts with and stabilizes ATP-binding cassette transporter A1 and enhances cholesterol efflux from cells. / J Biol Chem 2003,278(52):52379鈥?2385. CrossRef
10. Lee-Rueckert M, Vikstedt R, Metso J, Ehnholm C, Kovanen PT, Jauhiainen M: Absence of endogenous phospholipid transfer protein impairs ABCA1-dependent efflux of cholesterol from macrophage foam cells. / J Lipid Res 2006,47(8):1725鈥?732. CrossRef
11. Samyn H, Moerland M, van Gent T, van Haperen R, Grosveld F, van Tol A, de Crom R: Elevation of systemic PLTP, but not macrophage-PLTP, impairs macrophage reverse cholesterol transport in transgenic mice. / Atherosclerosis 2009,204(2):429鈥?34. CrossRef
12. van Haperen R, Samyn H, Moerland M, van Gent T, Peeters M, Grosveld F, van Tol A, de Crom R: Elevated expression of phospholipid transfer protein in bone marrow derived cells causes atherosclerosis. / PLoS One 2008,3(5):e2255. CrossRef
13. Oka T, Yamashita S, Kujiraoka T, Ito M, Nagano M, Sagehashi Y, Egashira T, Nanjee MN, Hirano K, Miller NE, / et al.: Distribution of human plasma PLTP mass and activity in hypo- and hyperalphalipoproteinemia. / J Lipid Res 2002,43(8):1236鈥?243.
14. Samyn H, Moerland M, van Gent T, van Haperen R, van Tol A, de Crom R: Reduction of HDL levels lowers plasma PLTP and affects its distribution among lipoproteins in mice. / Biochim Biophys Acta 2009,1791(8):790鈥?96.
15. Siggins S, Jauhiainen M, Olkkonen VM, Tenhunen J, Ehnholm C: PLTP secreted by HepG2 cells resembles the high-activity PLTP form in human plasma. / J Lipid Res 2003,44(9):1698鈥?704. CrossRef
16. Marques-Vidal P, Jauhiainen M, Metso J, Ehnholm C: Transformation of high density lipoprotein 2 particles by hepatic lipase and phospholipid transfer protein. / Atherosclerosis 1997,133(1):87鈥?5. CrossRef
17. Jauhiainen M, Ehnholm C: Determination of human plasma phospholipid transfer protein mass and activity. / Methods 2005,36(2):97鈥?01. CrossRef
18. Pussinen PJ, Jauhiainen M, Metso J, Pyle LE, Marcel YL, Fidge NH, Ehnholm C: Binding of phospholipid transfer protein (PLTP) to apolipoproteins A-I and A-II: location of a PLTP binding domain in the amino terminal region of apoA-I. / J Lipid Res 1998,39(1):152鈥?61.
19. Liu R, Hojjati MR, Devlin CM, Hansen IH, Jiang XC: Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis. / Arterioscler Thromb Vasc Biol 2007,27(1):190鈥?96. CrossRef
20. Tollefson JH, Ravnik S, Albers JJ: Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. / J Lipid Res 1988,29(12):1593鈥?602.
21. Kockx M, Rye KA, Gaus K, Quinn CM, Wright J, Sloane T, Sviridov D, Fu Y, Sullivan D, Burnett JR, / et al.: Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux. / J Biol Chem 2004,279(25):25966鈥?5977. CrossRef
22. Lagrost L, Desrumaux C, Masson D, Deckert V, Gambert P: Structure and function of the plasma phospholipid transfer protein. / Curr Opin Lipidol 1998,9(3):203鈥?09. CrossRef
23. Oka T, Kujiraoka T, Ito M, Egashira T, Takahashi S, Nanjee MN, Miller NE, Metso J, Olkkonen VM, Ehnholm C, / et al.: Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive. / J Lipid Res 2000,41(10):1651鈥?657.
24. Karkkainen M, Oka T, Olkkonen VM, Metso J, Hattori H, Jauhiainen M, Ehnholm C: Isolation and partial characterization of the inactive and active forms of human plasma phospholipid transfer protein (PLTP). / J Biol Chem 2002,277(18):15413鈥?5418. CrossRef
25. Cheung MC, Albers JJ: Active plasma phospholipid transfer protein is associated with apoA-I- but not apoE-containing lipoproteins. / J Lipid Res 2006,47(6):1315鈥?321. CrossRef - 作者单位：Marius R Robciuc (1)
Jari Metso (1)
Anca Sima (2)
Christian Ehnholm (1)
Matti Jauhiainen (1)
1. National Institute for Health and Welfare, Public Health Genomics Research Unit and FIMM, Institute for Molecular Medicine Finland, Haartmaninkatu 8, Biomedicum, Helsinki, Finland
2. Institute of Cellular Biology and Pathology "Nicolae Simionescu", B. P, Hasdeu 8, Bucharest, Romania
文摘
Background phospholipid transfer protein (PLTP) plays important roles in lipoprotein metabolism and atherosclerosis and is expressed by macrophages and macrophage foam cells (MFCs). The aim of the present study was to determine whether the major protein from HDL, apoA-I, affects PLTP derived from MFCs. Results as cell model we used human THP-1 monocytes incubated with acetylated LDL, to generate MFC. The addition of apoA-I to the cell media increased apoE secretion from the cells, in a concentration dependent fashion, without affecting cellular apoE levels. In contrast, apoA-I had no effect on PLTP synthesis and secretion, but strongly induced the PLTP activity in the media. ApoA-I also increased phospholipid transfer activity of PLTP isolated from human plasma. This effect was dependent on apoA-I concentration but independent on apoA-I lipidation status. ApoE, ApoA-II and apoA-IV, but not immunoglobulins or bovine serum albumin, also increased PLTP activity. We also report that apoA-I protects PLTP from heat inactivation. Conclusion apoA-I enhances the phospholipid transfer activity of PLTP secreted from macrophage foam cells without affecting the PLTP mass.